Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
88.00    0.00 (0.00%)
Bid:
86.00
Ask:
90.00
Spread: 4.00 (4.651%)
Market Cap: £98.77m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Form 8.3 - Rightster Group Plc

20 Oct 2015 13:27

OPENING POSITION DISCLOSURE FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Invesco Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Rightster Group Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19 October 2015
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

GB00BF8HJ774 Common Shares

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 65,593,102 17.84
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

65,593,102 17.84

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of Relevant Security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 20 October 2015
Contact name: Daniel Banayo
Telephone number: 01491 417 447

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151020005926/en/

Copyright Business Wire 2015

Date   Source Headline
1st Jun 20267:00 amRNSProposed Long Term Incentive Plan
27th May 20267:00 amRNSMello Investor Presentation
18th May 20267:00 amRNSAnnual Report, Notice of AGM & Dividend Dates
6th May 20267:00 amRNS-RMajor Contract Win
5th May 20267:00 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSNED Appointment
30th Apr 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSNotice of Results & Investor Presentation
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
6th Mar 20264:56 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20263:30 pmRNSTVR
2nd Mar 20267:10 amRNSStrategic Investment in System1
2nd Feb 20267:00 amRNSMajor Contract Win
29th Jan 202610:12 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSTrading Update
19th Dec 20253:00 pmRNSUpdate on Issue of Equity
12th Dec 20252:58 pmRNSExercise of Options, Issue of Equity and TVR
5th Dec 20254:00 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSResponse to Press Speculation
29th Oct 20257:00 amRNSAppointment of Joint Broker
24th Oct 20255:09 pmRNSResult of General Meeting
24th Oct 20253:00 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSHolding(s) in Company
8th Oct 20252:47 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of GM - Recommendation to Vote Against
1st Oct 202512:42 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSRequisition of General Meeting
25th Sep 202510:10 amRNSExercise of LTIP, Director Dealings and TVR
24th Sep 20253:52 pmRNSShareholder Update
23rd Sep 20257:00 amRNSHolding(s) in Company
22nd Sep 202511:32 amRNSHolding(s) in Company
11th Sep 20257:01 amRNSAcquisition and Trading Update
11th Sep 20257:00 amRNSInterim Results
10th Sep 20253:00 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of Results & Investor Presentation
1st Sep 20259:15 amRNSHolding(s) in Company
4th Aug 202511:34 amRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
17th Jul 20255:27 pmRNSHolding(s) in Company
17th Jul 20258:21 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.